The Korea Times close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Business
  • Tech
  • Bio
  • Companies
Finance
  • Companies
  • Economy
  • Markets
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
Entertainment
& Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
Sports
World
  • SCMP
  • Asia
Video
  • Culture
  • People
  • News
Photos
  • Photo News
  • Darkroom
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Fri, May 27, 2022 | 06:13
Health & Science
Korea OKs use of AstraZeneca vaccine for all adults
Posted : 2021-02-10 16:18
Updated : 2021-03-16 15:18
Print Preview
Font Size Up
Font Size Down
Food and Drug Safety Minister Kim Gang-lip speaks during a press conference at the ministry in Cheongju, North Chungcheong Province, Wednesday, on the conditional approval of AstraZeneca's coronavirus vaccine for all age groups including people aged 65 or older. Yonhap
Food and Drug Safety Minister Kim Gang-lip speaks during a press conference at the ministry in Cheongju, North Chungcheong Province, Wednesday, on the conditional approval of AstraZeneca's coronavirus vaccine for all age groups including people aged 65 or older. Yonhap

By Bahk Eun-ji

The Ministry of Food and Drug Safety said Wednesday it has approved the use of the COVID-19 vaccine made by AstraZeneca for all adults despite lingering concerns over its efficacy and safety especially for the elderly.

The decision is contrary to that made by a dozen other countries which have either not approved use of the vaccine from the British-Swedish pharmaceutical firm and Oxford University or have recommended against giving shots to people aged over 65.

Following the decision, anti-coronavirus inoculations are set to begin Feb. 26, with the AstraZeneca vaccine being the first to be administered before vaccines from other companies arrive.

The ministry said that it decided to approve the use of the AstraZeneca vaccine for adults aged over 18 on condition that the pharmaceutical company submits further data on clinical trials.

The decision was made at a third review by the ministry's panels of experts. Earlier in the first assessment, participants said it would be okay to administer the vaccine to adults of all ages, while the second review group concluded that further study of its efficacy and safety for senior citizens would be needed.

"The final review panel for the vaccine concluded that it is effective in the elderly, but use for senior citizens aged 65 or older should be carefully determined according to each person's health," Drug Safety Minister Kim Gang-lip said in a press briefing Wednesday.

With the approval, vaccinations will proceed according to the plan devised by the Korea Disease Control and Prevention Agency (KDCA).

The KDCA said it will begin by vaccinating 776,900 people including medical staff and elderly people at geriatric hospitals in the rest of first quarter. Many of the elderly here are thus likely to get the AstraZeneca vaccine.

The agency said it would finalize the list of vaccination recipients in the first quarter by Feb. 19. Exactly when to begin inoculations will be decided on later by its own panel of experts.

While the government here has given a positive response to the AstraZeneca vaccine, several countries have advised caution when vaccinating those over 65, mainly due to insufficient data on its safety for the elderly.

Regulators of a number of European countries including France, Germany, Sweden and Austria have questioned whether the vaccine from the company should be given to them at all ― the four decided to prioritize AstraZeneca use for those younger than 65.

Meanwhile, a survey of 1,068 adults conducted from Feb. 5 to 8 by Seoul National University's Graduate School of Public Health showed 56.8 percent of Koreans want to get the coronavirus vaccine sooner than the order that will be set by the government.

In a similar survey conducted by the school a month earlier, 67.7 percent of respondents answered that they would get the vaccine after checking on whether those getting the shots first were fine.

In the meantime, the KDCA said all Korean nationals arriving from abroad must submit a negative result from a polymerase chain reaction (PCR) coronavirus test before embarking for the country, starting from Feb. 24. Last month, the government mandated all foreign arrivals to submit negative PCR test results.

The toughened regulation came as the number of virus variant cases from the United Kingdom, Brazil and South Africa has been growing here.

Regardless of nationality, all arrivals should undergo a total of three diagnostic tests, one before departure, one immediately after entry and one before being released from the mandatory 14-day self-quarantine.


Emailejb@koreatimes.co.kr Article ListMore articles by this reporter
 
  • Corporate sponsors in dilemma over Son Heung-min's skyrocketing model fee
  • Why doesn't US want to add South Korea to Quad?
  • Supreme Court upholds 1 1/2-yr prison term for disgraced K-pop star Seungri
  • Blackpink celebrates Queen's birthday
  • British TV presenter views 'brutal' netizens as challenge to Korean entertainment
  • South Korean military to start using more advanced helmets this year
  • Undocumented resident gets 1.5-year jail term for financing Syria-based terrorist group
  • Desperation becomes sorrow after elementary school shooting
  • Employers criticize Supreme Court ruling against peak wage system
  • [INTERVIEW] Korea should open bio-related big data to private sector
  • Webtoon 'Navillera' nominated for renowned Eisner Award Webtoon 'Navillera' nominated for renowned Eisner Award
  • Former GFriend member Yuju sings on track for drama 'Kiss Sixth Sense' Former GFriend member Yuju sings on track for drama 'Kiss Sixth Sense'
  • Tim Burton's iconic world of misunderstood misfits returns to Korea Tim Burton's iconic world of misunderstood misfits returns to Korea
  • Park Chan-wook's 'Decision to Leave' draws favorable media reviews at Cannes Park Chan-wook's 'Decision to Leave' draws favorable media reviews at Cannes
  • [INTERVIEW] 'We want to help Korean dancers build global fandoms' [INTERVIEW] 'We want to help Korean dancers build global fandoms'
DARKROOM
  • 75th Cannes Film Festival

    75th Cannes Film Festival

  • People in North Korea trapped in famine and pandemic

    People in North Korea trapped in famine and pandemic

  • 2022 Pulitzer Prize: Bearing witness to history

    2022 Pulitzer Prize: Bearing witness to history

  • Worsening drought puts millions at risk

    Worsening drought puts millions at risk

  • Our children deserve the best

    Our children deserve the best

The Korea Times
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Location
  • Media Kit
  • Contact Us
  • Products & Service
  • Subscribe
  • E-paper
  • Mobile Service
  • RSS Service
  • Content Sales
  • Policy
  • Privacy Statement
  • Terms of Service
  • 고충처리인
  • Youth Protection Policy
  • Code of Ethics
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group